Dexcom^®, Inc., a medical device company founded in 1999, designs, develops, and commercializes continuous glucose monitoring systems. The company's current commercial offering is the FDA approved SEVEN^® PLUS system, which also has CE Mark approval for commercialization in the European Union, Latin America and Asian countries. Dexcom has joint development agreements with insulin pump manufacturers Animas^® Corporation, a subsidiary of Johnson & Johnson, and Insulet Corporation.  Dexcom and Edwards Lifesciences LLC, have an agreement to develop products for continuously monitoring blood glucose levels in hospitalized patients. Dexcom’s first generation hospital system received CE Mark approval in 2009.  Dexcom is located in San Diego, CA.